On the other hand, a non-invasive, no-prep test such as EXAS’ ColoGuard can be repeated often, allowing the cumulative sensitivity of a series of tests to be impressively high for both cancer and pre-cancer even when the sensitivity of each individual test is only middling.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.